| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 26, 2003
Accepted on February 10, 2004
Medical Clinic IV, University of Tübingen, Tübingen, 72076 Germany
* To whom correspondence should be addressed. E-mail: reiner.lammers{at}med.uni-tuebingen.de.
The atypical isoforms of protein kinase C (aPKCs) play an important role in insulin signaling and are involved in insulin stimulated glucose uptake in different cell systems. On the other hand, aPKCs also are able to negatively regulate important proteins for insulin signaling, like phosphatidyl-inositol-3-kinase (PI3K) and protein kinase B/Akt. To find aPKC-interacting proteins that may promote positive or negative activities of aPKCs, a yeast-2-hybrid-screen was performed. Partitioning-defective-protein 6 (Par6) was detected in human cDNA libraries of different adult insulin sensitive tissues. Although Par6 is known as an aPKC-interacting protein during development, no role for Par6 in insulin signaling has been reported so far. We therefore studied the effects of Par6 overexpression in C2C12 murine myoblasts. In these cells, Par6 associated constitutively with endogenous aPKCs, and the expression level as well as the activity of aPKCs were increased. Insulin-dependent association of the p85 subunit of PI3K with insulin-receptor-substrate1 (IRS1) was hampered and the phosphorylation of Akt/glycogen-synthase-kinase-3
/
was significantly impaired after stimulation with insulin or with platelet-derived-growth-factor. Consequently, insulin-dependent glycogen synthesis was down-regulated (1.44 vs. 2.24 fold, P < 0.01). We therefore suggest that Par6 acts as a negative regulator of the insulin signal.
This article has been cited by other articles:
![]() |
P. Labhart, S. Karmakar, E. M. Salicru, B. S. Egan, V. Alexiadis, B. W. O'Malley, and C. L. Smith Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator PNAS, February 1, 2005; 102(5): 1339 - 1344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |